1. Home
  2. RENX vs MTNB Comparison

RENX vs MTNB Comparison

Compare RENX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$2.05

Market Cap

4.7M

Sector

N/A

ML Signal

N/A

Logo Matinas Biopharma Holdings Inc.

MTNB

Matinas Biopharma Holdings Inc.

HOLD

Current Price

$0.73

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
MTNB
Founded
2021
2013
Country
United States
United States
Employees
38
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RENX
MTNB
Price
$2.05
$0.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
124.8K
18.9K
Earning Date
05-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.84
EPS
N/A
N/A
Revenue
N/A
$119,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.48
52 Week High
$3.48
$3.09

Technical Indicators

Market Signals
Indicator
RENX
MTNB
Relative Strength Index (RSI) 60.32 60.52
Support Level $1.62 $0.57
Resistance Level $2.21 $0.78
Average True Range (ATR) 0.12 0.06
MACD 0.03 0.00
Stochastic Oscillator 74.77 48.42

Price Performance

Historical Comparison
RENX
MTNB

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Share on Social Networks: